Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Safety and Efficacy of Interferon γ in Friedreich's Ataxia

This study reports the results of an open-label clinical trial testing the safety and efficacy of recombinant human interferon γ (IFNγ)-1b in a group of 12 young FRDA patients treated for 6 months.

Read the entire article HERE




Archived in
  Scientific News



Tagged in
FARA Scientific News

Site Map     Privacy Policy      Service Terms      Contact      Charity Navigator